-
TRIB3, Ferroptosis, and Sunitinib Sensitivity in ccRCC
2026-09-30
The reference study identifies TRIB3 as a contributor to sunitinib resistance in clear cell renal cell carcinoma and links its depletion to ferroptosis through the SLC7A11/GPX4 pathway. Its combination of expression analysis, TRIB3 knockdown, and drug-response experiments suggests a mechanistic route for improving sunitinib sensitivity, while also highlighting the need for validation beyond cellular models.
-
PAD4-IN-2 TFA: From NET Biology to Translation
2026-09-30
PAD4-IN-2 TFA, also known as Compound 5i TFA, offers a tumor-biased strategy for studying the PAD4–H3cit–NET axis. This thought-leadership guide translates preclinical findings into practical assay design, biomarker planning, safety assessment, and translational oncology strategy.
-
Pomalidomide (CC-4047) Myeloma Assay Workflows
2026-09-29
Build more informative multiple myeloma assays by pairing Pomalidomide response curves with cytokine, viability, and genomic-context measurements. This workflow also shows how CC-4047 can support erythroid progenitor cell differentiation studies while avoiding common solubility, model-selection, and interpretation errors.
-
Dimetridazole: From Assay Signal to Mechanism
2026-09-29
Dimetridazole research requires more than selecting an antimicrobial concentration. This article explains how redox chemistry, microbial physiology, quorum sensing, biofilm formation, and environmental transformation influence interpretation of bacterial culture assays and infection model research.
-
Wnt agonist 1 in Wnt-Driven Resistance Research
2026-09-28
Use Wnt agonist 1 (BML-284) to test whether canonical Wnt activation is sufficient to alter downstream resistance-associated biology—not to assume that it reproduces a metastatic phenotype. A staged reporter-to-mechanism workflow connects pathway activation with the GPX4 findings in lung cancer brain metastasis while keeping compound-specific effects experimentally distinct.
-
HyperFusion High-Fidelity DNA Polymerase for PCR
2026-09-27
For neurogenetics and other demanding workflows, HyperFusion™ high-fidelity DNA polymerase supports accurate amplification of difficult targets used in genotyping, construct validation, cloning, and sequencing-library preparation. This practical guide translates a C. elegans pheromone-neurodegeneration study into PCR assay choices, with starting conditions and troubleshooting guidance clearly separated from the study’s findings.
-
Substrate Stiffness Drives Dentinogenesis Through FAK
2026-09-26
Bai and colleagues report that substrate stiffness promotes dentinogenic behavior in odontoblast-like cells through a LAMB1–FAK–MEK1/2 signaling axis. Their in vitro findings connect cell–material mechanics with cell spreading, mineralization, and dentinogenesis-related gene expression, offering a mechanistic basis for future dental biomaterial studies.
-
Reserpine (N1867): Practical Lab Workflow Guide
2026-09-26
Reserpine (N1867) provides a characterized research compound for controlled neurotransmitter depletion, antihypertensive mechanism, and neuropharmacology studies, with product-specific information on purity, solubility, and storage. It is for laboratory research only—not diagnostic, therapeutic, clinical, or veterinary use—and solutions should be freshly prepared for experimental work.
-
Catalpol in Alzheimer’s Research: A Mechanism Map
2026-09-25
Catalpol offers a useful framework for investigating how oxidative stress, inflammation, and neuronal injury intersect in Alzheimer’s disease models. This article translates a focused literature review into an evidence-aware strategy for choosing assays, interpreting results, and distinguishing AD-specific findings from hypotheses drawn across disease models.
-
Nitrocefin for β-Lactamase Assay Workflows
2026-09-25
Use Nitrocefin to turn β-lactamase activity into a visible, measurable signal—then build controls around the enzyme question you are asking. This workflow connects the GOB-38 findings in Elizabethkingia anophelis to practical activity measurement and inhibitor-screening experiments, while clarifying what a color change can—and cannot—show.
-
SNAI1 Drives EMT and Stemness in Thymic Tumors
2026-09-24
This study identifies SNAI1 as a candidate oncogenic hub in thymic epithelial tumors and links its effects on epithelial–mesenchymal transition and cancer stem cell-like traits to a PIK3R2/p-EphA2 signaling axis. By combining patient-data analysis with cellular, animal, single-cell, and molecular assays, the work offers a mechanistic framework for further testing—not a validated treatment strategy.
-
Of chloroquine and COVID-19: what prior evidence showed
2026-09-24
Touret and de Lamballerie place early interest in chloroquine for COVID-19 against a broad record of antiviral research, emphasizing that cell-culture activity has often failed to translate into clinical benefit. Their commentary highlights both the limits of extrapolating across viruses and the possibility that drug effects on host responses can worsen outcomes.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-09-23
Hydroxychloroquine Sulfate provides an aqueous-compatible perturbation for short-term studies of autophagy pathway modulation and TLR7/9-dependent immune signaling in autoimmune disease research. It is appropriate for locally validated cellular or animal workflows, but not for protocols requiring DMSO or ethanol solubility or long-term storage of prepared solutions.
-
H 89 2HCl: Reliable PKA Pathway Assays
2026-09-23
Learn how H 89 2HCl (SKU B2190) can help researchers distinguish cAMP/PKA pathway effects from nonspecific changes in viability, proliferation, or cytotoxicity assays. This scenario-driven guide covers experimental design, dosing, controls, interpretation, and practical product-selection criteria.
-
Ferritin Hybrid Particles for Influenza–COVID-19 Vaccination
2026-09-22
The reference study developed an Escherichia coli-produced ferritin hybrid particle displaying influenza A M2e and SARS-CoV-2 S-protein tandem epitopes in one recombinant design. In mice, the hybrid particle enhanced antigen-specific responses and generated sera with pseudovirus-inhibitory, cell-binding, and ADCC activity, supporting ferritin as a practical platform for combination vaccine development.